NANOBIOTIX Announces Updated Preliminary Results From Phase 1 Pancreatic Cancer Trial and New Exploratory Analysis From Completed Phase 1 Head and Neck Cancer Trial at ESMO 2023

By / 23/10/2023

NANOBIOTIX announced updated data from two presentations at the 2023 Annual Congress of the European Society for Medical Oncology.